A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
NCT04226963 · GDKet · Medical University of Gdansk
What it is testing
Summary
Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.
What counts as success
Primary outcome measures
Incidence of adverse events assessed by Clinical-Administered Dissociative Symptoms Scale (CADSS)
Measured over Baseline through week 5
Incidence of adverse events assessed by 4-items positive symptoms subscale of Brief Psychiatric Rating Scale (BPRS)
Measured over Baseline through week 5
Incidence of adverse events assessed by body temperature (oral measurements)
Measured over Baseline through week 5
Incidence of adverse events assessed by blood pressure
Measured over Baseline through week 5
Incidence of adverse events assessed by respiration rate
Measured over Baseline through week 5
Incidence of adverse events assessed by pulse
Measured over Baseline through week 5
Incidence of adverse events assessed by blood oxygen saturation
Measured over Baseline through week 5
Incidence of adverse events assessed by weight
Measured over Baseline and week 5
Incidence of adverse events assessed by height
Measured over Baseline
A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.
Who can take part
Eligibility, as published
Where
1 study site
| Facility | City | Region | Country |
|---|---|---|---|
| Department of Psychiatry, Medical University of Gdańsk | Gdansk | — | Poland |
On the registry
Contact the trial directly
This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.
Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.
NCT04226963 on ClinicalTrials.gov →
Last updated in the registry 2023-09-28. Registry records change; this page reflects the data build of 2026-08-25.
Related